Improvement of depressive symptoms in patients with severe atopic dermatitis treated with dupilumab: an open-label trial validated using the Beck depression inventory, Hamilton depression rating scale measures, and 18F-fluorodeoxyglucose positron emission tomography

Eur J Dermatol. 2026 Feb 1;36(1):73-75. doi: 10.1684/ejd.2026.4726.
No abstract available